Genetic mutations or altered expression levels of GRIN3A in humans are implicated in cognitive deficits and diverse neurological/neuropsychiatric conditions such as schizophrenia, bipolar disorder, addiction, epilepsy, and Huntington's Disease 13,32–39. This evidence concerns the gene GRIN3A and Huntington disease.